TMCI
HoldHot AirTreace Medical Concepts, Inc. · Healthcare · United States · $293M
$3.89 -2.7% · close 7 Oct · scored 9 Oct
Hot Air: Rising on momentum alone: weak business, rich price.
Read our full research report on TMCI (Jun 2026), freeDoes StockRank work? Each month we publish how every decile did, whichever way it went. See the record →
ABOUT TREACE MEDICAL CONCEPTS, INC.
Read
Treace Medical Concepts, Inc. is a medical device company focused on advancing the standard of care for bunion surgery through its proprietary Lapiplasty 3D Bunion Correction system. The company's competitive moat is established by its unique instrumentation, extensive clinical data supporting superior patient outcomes, and a highly specialized direct sales force. It operates as a dominant niche leader in the foot and ankle orthopedic market.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 141.8M | 187.1M | 209.4M | 212.7M | 14.5% | 205.3M | 207.5M | 221.8M | 2.1% |
| EPS | -0.77 | -0.81 | -0.90 | -0.93 | — | -0.92 | -0.85 | -0.85 | — |
| Shares | 55.6M | 61.7M | 62.4M | 63.9M | +14.8% | 65.0M | — | — | — |
| Debt | 68.6M | 70.3M | 69.7M | 71.9M | 1.6% | 73.0M | — | — | — |
| Equity | 60.5M | 137.9M | 112.9M | 87.3M | 13.0% | — | — | — | — |
| Op CF | -30.6M | -34.6M | -37.2M | -16.0M | — | -14.6M | — | — | — |
| Inv CF | -76.5M | -81.3M | 35.4M | 13.3M | — | — | — | — | — |
| Fin CF | 20.8M | 109.4M | 0.2M | 2.1M | — | — | — | — | — |
Swung more than 92% of stocks we rank over the past year (87% a year).
How this is worked out
What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of TMCI are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| TMCI | Treace Medical Concepts, Inc.(you) | $293M | 38 | Hold |
| OFIX | Orthofix Medical Inc. | $371M | 34 | Sell |
| STIM | Neuronetics, Inc. | $219M | 33 | Sell |
| AVH.AX | AVITA Medical, Inc. | $335M | 47 | Hold |
| LAB | Standard BioTools Inc. | $291M | 24 | Sell |
| PACB | Pacific Biosciences of California, Inc. | $438M | 29 | Sell |
| SGHT | Sight Sciences, Inc. | $468M | 45 | Hold |
| TLSI | TriSalus Life Sciences, Inc. | $308M | 21 | Sell |
| CERS | Cerus Corporation | $524M | 31 | Sell |
| QDEL | QuidelOrtho Corporation | $709M | 38 | Hold |
Peer medians: ROE -30.9% · P/E 25.1x · Gross margin 63.3%
Company Deep Dive
Read the full research report: business segments breakdown, earnings transcripts review, management credibility analysis, competitive landscape, and scenarios.